أوقيانوسيا · الأسواق الإقليمية · The Motley Fool Australia

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

نشره The Motley Fool Australia · أستراليا منذ 2 س

Telix Pharmaceuticals' Q3 2026 update sees strong revenue growth, FDA milestones, and a major merger to expand its radiopharmaceuticals platform. The post Telix Pharmaceuticals Q3…

اقرأ المقال كاملًا على The Motley Fool Australia سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.fool.com.au)

يستحق القراءة أيضًا

Business News (WA)

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Market Index

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

SmartCompany

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

مشاركة

يستحق القراءة أيضًا

Woodside confirms plan to sell down $3.3b project after two years of ownership

GAMING: 6 of the best indie games from the PAX Australia show floor

Transport costs to Sydney's new airport: Is it worth it for you?

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail